We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





College of American Pathologists Releases New Proficiency Testing Program for Detection of SARS CoV-2

By LabMedica International staff writers
Posted on 11 Apr 2020
Print article
Illustration
Illustration
The College of American Pathologists {(CAP) Northfield, IL, USA) has responded to the global coronavirus disease (COVID-19) pandemic by releasing a new proficiency testing (PT) program for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). PT is used to gauge the performance of individual laboratories for specific tests and monitors continuing performance while comparing performance with other laboratories.

The CAP is an organization of board-certified pathologists and a leading provider of laboratory accreditation and proficiency testing programs that serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. The CAP offers the most comprehensive PT programs that CAP members, along with other scientists, scientifically develop and validate. More than 22,000 laboratories across the world are enrolled in the CAP’s PT programs.

The Microbiology Committee members piloted the new program with a set of laboratories prior to making it available, allowing committee members and CAP staff to verify specimen performance across the multiple methods and testing platforms. Specifically, the program is for the detection of SARS-CoV-2 by nucleic acid amplification testing. Further, it provides samples that are non-infectious and target consensus gene regions N, E, RdRp, S, and ORF1a, as well as allows laboratories to assess their entire workflow from nucleic acid extraction through detection.

“In the midst of the enormous pressure laboratories are facing, along with everyone working in health care during the COVID-19 crisis, laboratories are seeking to measure their performance when testing for the disease,” said Raouf Nakhleh, MD, FCAP, chair of the CAP’s Council on Scientific Affairs. “The CAP’s Microbiology Committee quickly came together to develop this high-quality program.”

Related Links:
College of American Pathologists

Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.